Recombinant technology in medical research and therapeutics
Ranasinghe, L.
Ceylon Medical Journal 28(2): 57-61
1983
ISSN/ISBN: 0009-0875 PMID: 6677401 Document Number: 215683
Document emailed within 1 workday
Related Documents
Szomolányi, E.; Nász, I. 1984: Recombinant DNA technology in adenovirus research Acta Virologica 28(1): 84-92Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Lerch, H.; Jigalin, A. 2005: Nuclear medicine: medical technology research Nuklearmedizin. Nuclear Medicine 44(6): 267-271
Giles, R.V. 2000: Antisense oligonucleotide technology: from EST to therapeutics Current Opinion in Molecular Therapeutics 2(3): 238-252
Felgner, P.L.; Zaugg, R.H.; Norman, J.A. 1995: Synthetic recombinant DNA delivery for cancer therapeutics Cancer Gene Therapy 2(1): 61-65
Tebbutt, S.J. 2000: Technology evaluation: transgenic alpha-1-antitrypsin (AAT), PPL therapeutics Current opinion in molecular therapeutics 2(2): 199-204
Fujimasa, I. 1973: Technics in educational technology in medical education--a new methodology in medical education to meet the needs of modern medical technology Nursing Technique 19(10): S: 90-S: 100
Mehr, S.R. 2006: The evolutionary role of the pharmacy and therapeutics committee in technology assessment Managed Care Interface 19(1): 42-45
Grünweller, A.; Hartmann, R.K. 2016: Chemical modification of nucleic acids as a key technology for the development of RNA-based therapeutics Die Pharmazie 71(1): 8-16
Darling, K. 1986: United States Department of Agriculture statement before the Subcommittee on Investigations and Oversight, Subcommittee on Natural Resources, Agriculture Research and Environment, Subcommittee on Science, Research and Technology, U.S. House of Representatives Committee on Science and Technology, July 23, 1986 Recombinant Dna Technical Bulletin 9(3): 195-202
Shvaloff, A.; Neuman, E.; Guez, D. 1996: Lines of therapeutics research in Alzheimer's disease Psychopharmacology Bulletin 32(3): 343-352
1990: Interim assessment: carotid endarterectomy. Report of the American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee Neurology 40(4): 682-683
Berger, M.S.; Keles, G.Evren. 2004: Translational research strategies applied to glioma therapeutics Clinical Neurosurgery 51: 203-206
Slavkin, H.C. 1989: Recombinant DNA technology and clinical dentistry International Journal of Prosthodontics 2(1): 80-96
Moudgil, K.D. 1986: Recombinant DNA technology: clinical prospects Indian Pediatrics 23(7): 489-492
Thomas, L. 1977: Ethical issues in scientific research; two views on recombinant DNA research Federation Proceedings 36(11): I-Ii
Gruppen, L.D.; Yoder, E.; Frye, A.; Perkowski, L.C.; Mavis, B. 2011: Supporting medical education research quality: the Association of American Medical Colleges' Medical Education Research Certificate program Academic medicine: journal of the Association of American Medical Colleges 86(1): 122-126
Yamamura, K. 1985: Application of recombinant DNA technology to clinical medicine Rinsho Byori. Japanese Journal of Clinical Pathology 33(5): 545-549
Montagnese, A.; Sturla, M.; Bruno, I.; Bracaglia, R.; Salgarello, M.; Seccia, A.; Farallo, E. 2003: Soft tissue sarcomas: research of prognostic factors and therapeutics scheme Journal of Experimental and Clinical Cancer Research: Cr 22(4 Suppl): 219-222
Korwek, E.L. 1981: OSHA regulation of industrial applications of recombinant DNA technology University of Cincinnati Law Review. University of Cincinnati. College of Law 50(2): 284-313